{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Opthea Limited"},"Symbol":{"label":"Symbol","value":"OPT"},"Address":{"label":"Address","value":"650 CHAPEL STREET,LEVEL 4, SUITE 0403, SOUTH YARRA, 3141, Australia"},"Phone":{"label":"Phone","value":"+61 398260399"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Australia and South Pacific"},"CompanyDescription":{"label":"Company Description","value":"Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.opthea.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Annie Lee","title":"Manager-Finance & Operations"},{"name":"Frédéric Guerard","title":"Chief Executive Officer"},{"name":"Ian Leitch","title":"Director-Clinical Research"},{"name":"John Han","title":"Vice President-Medical Affairs"},{"name":"Julie Clark","title":"Senior Vice President-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}